DTA mutations

Biomarker

4 papers mention it2 findings

See all 4 papers on DTA mutations

“DTA mutation was a risk factor for thrombotic event, being predictive for shorter thrombosis-free survival in the whole cohort (p = 0.007)”
DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational StudyThrombosis and haemostasis2024doi:10.1055/a-2239-9265

Effects

1

Thrombosis-free survival

downin humans1

1 study
  1. DTA mutations are linked with lower thrombosis-free survival in polycythemia vera patients (p = 0.007).

    Humansin polycythemia vera patientsn = 136

Associations

1

Thrombosis

upin humans1

1 study
  1. DTA mutations are linked with a higher risk of thrombosis in polycythemia vera patients.

    Humansin polycythemia vera patientsn = 136

More on Thrombosis

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 02 papers in 12 months